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RNase P is a ribonucleoprotein that cleaves the 5Ј leader sequence of pre-tRNA molecules to produce the mature 5Ј end. Escherichia coli RNase P is composed of a 119-amino-acid protein component (10) and an RNA component of 377 nucleotides (16) . The RNA component provides the catalytic activity (2) . The RNA alone is catalytic in vitro under highionic-strength conditions but is an extremely poor catalyst under low-ionic-strength conditions (8) . However, complementation with the protein component restores catalytic activity at low ionic strength. The protein component has an influence on both cleavage rate and substrate specificity (7, 9, 13) and may facilitate product release by means of ionic shielding (15) .
Studies on the protein component and the holoenzyme have been greatly hampered by difficulties in purifying high concentrations of functional RNase P protein (18, 19) . Herein we describe a procedure to purify soluble, active RNase P protein in high yield under native conditions by a single-step procedure that involves metal chelate affinity chromatography. We demonstrate that the purified, recombinant protein is functional by reconstitution of the RNase P holoenzyme followed by measuring processing of a Bacillus subtilis pre-tRNA His substrate. Cloning of E. coli RNase P protein. The E. coli rnpA gene coding for the protein component of RNase P was obtained by PCR from bacterial genomic DNA by using oligonucleotides complementary to the 5Ј and 3Ј regions of the rnpA gene plus added restriction sites (TTTGGATCCATGGTTAAGCTCGC ATTTCCC and TTTGAGCTCCAGGACCCGCGAGCCAG, respectively; The Midland Certified Reagent Company). The amplified DNA was sequenced (5) and cloned into vector pQE30 (Qiagen Inc.), which adds 12 residues (MRGSHHH-HHHGS) at the amino terminus of the RNase P protein, including a series of six histidines specifically engineered into this construct. This QIA Express (Qiagen) pQE expression vector combines the phage T5 promoter with a repression system to allow tight regulation of protein production by means of the lac operator/lac repressor and is induced by isopropylthiogalactopyranoside (IPTG).
Protein purification. E. coli cultures were grown at 37ЊC in LB broth (containing 100 g of ampicillin and 25 g of kanamycin per ml) to an approximate A 600 of 1.5. Protein expression was induced by addition of 2 mM IPTG (Sigma), and the cultures were further incubated for 2 h at 25ЊC. Cells were harvested at 4ЊC by centrifugation at 8,000 ϫ g. The cell pellet was resuspended in 2ϫ volumes of lysis buffer [50 mM TrisHCl, 10 mM Mg(C 2 H 3 O 2 ) 2 ⅐ 4H 2 O, 1 M NH 4 Cl, 0.25% Tween 20 (pH 7.9)] with protease inhibitors (pepstatin [1 g/ml] and antipain [2 g/ml]; Sigma). Cells were lysed by two cycles of freeze-thawing in dry ice-ethanol followed by six sonication pulses of 1 min each. The cell lysate was centrifuged at 14,000 ϫ g for 20 min at 4ЊC and the supernatant was collected and loaded onto a Ni 2ϩ -nitrilotriacetic acid column (Qiagen) preequilibrated with lysis buffer. The column was extensively washed with lysis buffer, and the protein was eluted with 0.5 M imidazole in 100 mM Tris-HCl (pH 8). Protein concentration was determined both by the bicinchoninic acid method (Pierce) and by the Lowry protein assay.
Expression levels of the recombinant protein were high in IPTG-induced cells, as determined by silver staining, in contrast to uninduced cells, in which the levels of recombinant protein were undetectable (not shown). Typical yields were of the order of 17 mg of pure, recombinant protein per liter of culture. Since the basis for the Ni 2ϩ -nitrilotriacetic acid column purification requires the histidine-tagged terminal sequence, endogenous C5 protein or holoenzyme would not stick to that column and would not be copurified with the recombinant C5 protein. In any case, levels of endogenous C5 protein or holoenzyme, as estimated from the work of Vioque and Altman (19) , are very low. They state that C5 is a very minor protein in E. coli, being present as about 250 copies per cell. Their one-step affinity chromatography procedure resulted in the purification of approximately 5 to 30 g/20 g of cells for the endogenous protein and about sixfold amplification with their recombinant protein. Our recombinant protein represents over a 1,000-fold amplification above this endogenous level. In addition to purified RNase P protein from E. coli, we have also isolated B. subtilis RNase P protein in soluble form by using the approach described herein (not shown) and are currently characterizing the functional activity of this recombinant protein.
Physical characterization. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Coomassie blue staining of the purified, recombinant protein revealed a single band of the expected size (not shown). The molecular weight of the recombinant protein was further verified by electrospray ionizationmass spectroscopy (ESI-MS; Fig. 1) . A single peak at 15,188.3 Da was observed, in agreement with a calculated molecular weight of 15,188.64 based on the expected amino acid composition of the recombinant protein including the histidine tag. From the ESI-MS data, we estimated a purity of greater than 95%.
Functional characterization. The recombinant protein was assayed for its ability to allow the catalytic RNA to complete 5Ј-end processing of a B. subtilis synthetic pre-tRNA His (1, 6). The E. coli M1 RNA was transcribed from T7 polymerase vectors (Promega Biotec) as previously described (4). Duplicate processing reactions were carried out for 3 min essentially as described previously (19) 4 Cl, 5% polyethylene glycol). The 3-min time point was well within the linear range of the reaction. The holoenzyme was reconstituted by a 5-min preincubation at 37ЊC of the RNA and protein components followed by substrate addition. The fraction of active protein was determined by titration versus a constant amount of E. coli catalytic RNA (1 nM) (4) and substrate (200 nM; 1.29 ϫ 10 16 cpm/mol). Reaction products were separated by electrophoresis, and gel slices corresponding to the 5Ј processed and unprocessed tRNA His were cut out and quantitated by scintillation counting to determine the extent of processing. As Table 1 shows, very similar levels of substrate processing were observed for the holoenzyme whether the protein component was in molar excess or in equimolar amounts with the RNA component. An approximately 46% decrease in product formation was observed for the holoenzyme when the molar ratio between protein and catalytic RNA was reduced from 1:1 to 0.5:1. No processed pre-tRNA His was observed when the recombinant protein or catalytic RNA was assayed alone in low-ionicstrength buffer or when the catalytic RNA alone was assayed in high-ionic-strength buffer. At this short incubation time, no processing was observed by the RNA alone because the rate of M1 alone is not sufficient to achieve processing in the absence of the protein during the time of the assay (14) . Average variation among duplicates was approximately Ϯ1% of product.
Implications.
Previous methods for the purification of recombinant RNase P protein resulted in low yields of Յ2 mg/l (20) or in protein preparations with as low as 25% active protein (18) . In contrast, herein we report yields of 17 mg of pure, recombinant RNase P protein per liter of culture and high protein activity as determined by enzymatic assays. It is unlikely that the observed solubility of the recombinant protein is the result of the extraneous residues incorporated during the cloning procedure. Little effect on protein function or structure has been reported for the hexahistidine sequence when this sequence is used with other protein constructs (3, 12, 17) . Our results indicate that the presence of these extraneous residues at the amino terminus of the recombinant protein does not interfere with protein function in the holoenzyme; The purification of RNase P protein in native, soluble form is of substantial importance as it now becomes possible to carry out more detailed analysis on the interaction of the protein and RNA components in the holoenzyme. In addition, soluble, native RNase P protein should be amenable to physical studies involving nuclear magnetic resonance spectroscopy, X-ray crystallography, and other techniques. These analyses, combined with available three-dimensional models of the catalytic RNA (11, 21) , should provide a detailed picture of the threedimensional structure of the RNase P holoenzyme and of its possible modes of interaction with pre-tRNAs and other substrates.
